Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

International Strategy and Market Performance in New Biotechnology Firms, Hardback Book

International Strategy and Market Performance in New Biotechnology Firms Hardback

Part of the Transnational Business and Corporate Culture series

Hardback

Description

The issues addressed in this study are: What internal factors support changes in the international operations of new firms? and What effect do these changes have on the firm's structure, control system, and market performance.

To answer these questions, this work examines the internal resources and market performance of a set of publicly traded biotechnology firms. Findings support the view that new firms can enter international markets through a variety of strategies, including international joint ventures and subsidiaries. Changes in international operations also are found to enhance firm market performance when accompanied by changes in firm structure and control systems. However, managers must be patient because market performance only improves significantly two years after these organizational changes have taken place.

Information

Other Formats

£145.00

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information